FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

11533111000001101: Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
42276201000001114 Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
42830601000001115 Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet 3 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet Is a Paroxetine 30mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet Is pack of Paroxetine 30mg tablets (Sandoz Ltd) false Inferred relationship Existential restriction modifier
Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet Has active ingredient Paroxetine hydrochloride false Inferred relationship Existential restriction modifier
Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet Has active ingredient Paroxetine false Inferred relationship Existential restriction modifier
Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet Has manufactured dose form Oral dose form false Inferred relationship Existential restriction modifier
Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet Has AMP Paroxetine 30mg tablets (Sandoz Ltd) true Inferred relationship Existential restriction modifier
Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Paroxetine true Inferred relationship Existential restriction modifier
Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet Has specific active ingredient Paroxetine hydrochloride true Inferred relationship Existential restriction modifier
Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Paroxetine 30mg tablets (Sandoz Ltd) 30 tablet Has basis of strength substance Paroxetine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start